Brian Bossetta
Senior Writer, US Policy & Regulation
Brian holds a BA in history from Loyola University of New Orleans, is a die-hard Saints fan, and loves running, classical music and jazz. He lives with his wife, Caroline, in New York’s magnificent Hudson Valley.
Latest From Brian Bossetta
Device Week, 28 July 2021 – US Medicare Reimbursement News And A Roundup Of UK Regulatory Changes
On this week’s podcast we highlight US Medicare reimbursement topics that industry should keep an eye on, and discuss important regulatory changes underway in the UK.
Senators Bring Back Bill Mandating Medicare Payment For Breakthrough Technologies
Four US senators are leading a bipartisan effort to bring potentially life-saving medical treatments to Medicare beneficiaries by requiring reimbursement for breakthrough technologies cleared by the FDA.
Slew Of Bills Addressing Cybersecurity And Immunization Pass Through Committee; Now Go Before Full House
The US House Committee on Energy and Commerce advanced multiple bipartisan bills focused on immunization, cybersecurity, addiction, and other health issues.
Glaukos Takes Another Hit From CMS; Investors Respond Negatively As Stock Falls
The US Medicare agency's new rule for facility fees brings more bad news for Glaukos; Wells Fargo downgrades company’s stock in response.
Biden Admin Looks To Broaden Telehealth, Increase Access To Mental Health Care
Proposals from the US Centers for Medicare & Medicaid Services (CMS) would help make telehealth a permanent fixture across the healthcare landscape, particularly for treating mental health.
Latest Physician Fee Schedule Proposal Could Impact Companies’ Bottom Line
The US Centers for Medicare & Medicaid Services (CMS) issued a proposed rule that includes new reimbursement levels for multiple medical devices, including the Glaukos iStent.